News Pfizer/BioNTech begin phase 1 of COVID-19/influenza combo BioNTech and Pfizer have announced that they are initiating a phase 1 study to evaluate a single dose mRNA-based combination
Sales & Marketing Biotech is back, with Craig Ackerman In Philadelphia this month, pharmaphorum spoke with Craig Ackerman, a partner at the Alexander Group, about launches, AI best practices, and more.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
